This page is historical material reflecting the Feedback Loop Blog as it existed on March 3, 2021. This page is no longer updated and links to external websites and some internal pages may not work.
March 3, 2021

Archived: Funding Opportunities: Urgent Competitive Revisions to NIGMS IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy

By Sheila Caldwell

We’re pleased to announce the availability of supplements to active INBRE (P20), COBRE (P20, P30), IDeA-CTR (U54), and NARCH (S06) awards to support vaccine hesitancy research relevant to SARS-CoV-2. The supplements are aimed at studying the causes of SARS-CoV-2 vaccine hesitancy in IDeA states and/or American Indian/Alaska Native communities, and at developing innovative evidence-based interventions to enhance vaccine acceptance with the goal of increased vaccine uptake.

Applications are due by April 30, 2021; see NOT-GM-21-021 for additional details.

If you have any questions about this supplement opportunity, please contact me.

topic Funding Opportunities
tag Administrative Supplements , COVID-19 , Institutional Development Award , Research Capacity Building

About the Author

Sheila Caldwell

Sheila Caldwell

Before leaving for NIH OD in 2023, Sheila managed the Native American Research Centers for Health (NARCH) program, as well as components of the Institutional Development Award (IDeA) program.